Ryosuke Suzuki

5.7k total citations
129 papers, 4.4k citations indexed

About

Ryosuke Suzuki is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Ryosuke Suzuki has authored 129 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Hepatology, 50 papers in Epidemiology and 31 papers in Infectious Diseases. Recurrent topics in Ryosuke Suzuki's work include Hepatitis C virus research (76 papers), Hepatitis B Virus Studies (42 papers) and Mosquito-borne diseases and control (30 papers). Ryosuke Suzuki is often cited by papers focused on Hepatitis C virus research (76 papers), Hepatitis B Virus Studies (42 papers) and Mosquito-borne diseases and control (30 papers). Ryosuke Suzuki collaborates with scholars based in Japan, United States and France. Ryosuke Suzuki's co-authors include Takaji Wakita, Tatsuo Miyamura, Yoshiharu Matsuura, Hideki Aizaki, Tetsuro Suzuki, Koichi Watashi, Koji Ishii, Masashi Iwamoto, Mami Matsuda and Kohji Moriishi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Ryosuke Suzuki

126 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryosuke Suzuki Japan 40 2.4k 2.4k 1.1k 762 499 129 4.4k
Philippe Roingeard France 42 1.9k 0.8× 2.2k 0.9× 1.1k 1.0× 951 1.2× 451 0.9× 146 4.6k
Guangxiang Luo United States 39 2.2k 0.9× 2.3k 1.0× 1.3k 1.2× 594 0.8× 217 0.4× 75 4.3k
Hideki Aizaki Japan 42 3.3k 1.4× 2.9k 1.2× 1.7k 1.6× 700 0.9× 241 0.5× 113 5.5k
Marlène Dreux France 32 2.5k 1.1× 2.6k 1.1× 1.2k 1.1× 694 0.9× 343 0.7× 51 4.8k
Timothy L. Tellinghuisen United States 21 3.3k 1.4× 2.7k 1.1× 1.1k 1.0× 687 0.9× 212 0.4× 29 4.5k
Pablo Gastaminza Spain 24 3.0k 1.2× 3.0k 1.3× 1.1k 1.0× 546 0.7× 221 0.4× 51 4.7k
Susan L. Uprichard United States 27 2.8k 1.2× 2.9k 1.2× 850 0.8× 504 0.7× 163 0.3× 72 4.3k
Koichi Watashi Japan 43 3.8k 1.6× 4.2k 1.8× 2.5k 2.3× 1.2k 1.5× 331 0.7× 192 7.7k
Alexander A. Kolykhalov United States 21 2.6k 1.1× 2.4k 1.0× 904 0.8× 1.3k 1.7× 203 0.4× 42 4.1k
Michael M. C. Lai United States 48 2.6k 1.1× 2.6k 1.1× 1.9k 1.8× 1.9k 2.5× 223 0.4× 104 6.5k

Countries citing papers authored by Ryosuke Suzuki

Since Specialization
Citations

This map shows the geographic impact of Ryosuke Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryosuke Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryosuke Suzuki more than expected).

Fields of papers citing papers by Ryosuke Suzuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryosuke Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryosuke Suzuki. The network helps show where Ryosuke Suzuki may publish in the future.

Co-authorship network of co-authors of Ryosuke Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Ryosuke Suzuki. A scholar is included among the top collaborators of Ryosuke Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryosuke Suzuki. Ryosuke Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, You, Ling Xie, Maryna Kapustina, et al.. (2025). Heat shock protein 90 chaperone activity is required for hepatitis A virus replication. Journal of Virology. 99(7). e0050225–e0050225. 1 indexed citations
3.
Matsuda, Mami, et al.. (2025). Tetravalent Virus-like Particles Engineered To Display Envelope Domain IIIs of Four Dengue Serotypes in Silkworm as Vaccine Candidates. Biomacromolecules. 26(3). 2003–2013. 3 indexed citations
4.
Matsuda, Mami, et al.. (2024). Expression of dengue capsid-like particles in silkworm and display of envelope domain III of dengue virus serotype 2. Protein Expression and Purification. 222. 106543–106543. 2 indexed citations
5.
Suzuki, Ryosuke, Rahma Hayati, Mya Myat Ngwe Tun, et al.. (2024). Impact of pre-existing cross-reactive antibodies on cyclic dengue outbreaks in the hyperendemic region of Bali, Indonesia. Virus Research. 348. 199445–199445. 2 indexed citations
6.
Kanda, Tatsuo, Tian‐Cheng Li, Masaharu Takahashi, et al.. (2024). Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection. Hepatology Research. 54(8). 1–30. 5 indexed citations
7.
Suzuki, Ryosuke, Mami Matsuda, Mya Myat Ngwe Tun, et al.. (2023). Role of pre-existing immunity in driving the dengue virus serotype 2 genotype shift in the Philippines: A retrospective analysis of serological data. International Journal of Infectious Diseases. 139. 59–68. 7 indexed citations
8.
Kanda, Tatsuo, Reina Sasaki, Koji Ishii, et al.. (2023). Recent advances in hepatitis A virus research and clinical practice guidelines for hepatitis A virus infection in Japan. Hepatology Research. 54(1). 4–23. 6 indexed citations
9.
Suzuki, Ryosuke & Tetsuro Suzuki. (2023). Reverse Genetics of Hepatitis C Virus Using an RNA Polymerase I-Mediated Transcription. Methods in molecular biology. 2733. 175–183. 1 indexed citations
10.
Shiota, Tomoyuki, Mami Matsuda, Koji Ishii, et al.. (2022). Macrophage Depletion Reactivates Fecal Virus Shedding following Resolution of Acute Hepatitis A inIfnar1–/–Mice. Journal of Virology. 96(23). e0149622–e0149622. 3 indexed citations
11.
Shinnakasu, Ryo, Shuhei Sakakibara, Hiromi Yamamoto, et al.. (2021). Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses. The Journal of Experimental Medicine. 218(12). 17 indexed citations
12.
Sun, Lu, You Li, Ichiro Misumi, et al.. (2021). IRF3-mediated pathogenicity in a murine model of human hepatitis A. PLoS Pathogens. 17(9). e1009960–e1009960. 13 indexed citations
13.
14.
Saito, Kyoko, Masayoshi Fukasawa, Yoshitaka Shirasago, et al.. (2020). Comparative characterization of flavivirus production in two cell lines: Human hepatoma-derived Huh7.5.1-8 and African green monkey kidney-derived Vero. PLoS ONE. 15(4). e0232274–e0232274. 10 indexed citations
15.
Shiota, Tomoyuki, Tian‐Cheng Li, Yorihiro Nishimura, et al.. (2019). Integrin α3 is involved in non-enveloped hepatitis E virus infection. Virology. 536. 119–124. 25 indexed citations
16.
Iwamoto, Masashi, Dawei Cai, Masaya Sugiyama, et al.. (2017). Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication. Scientific Reports. 7(1). 10620–10620. 41 indexed citations
17.
Mizutani, T., Yukichi Tanahashi, Ryosuke Suzuki, et al.. (2015). Threshold Voltage and Current Variability of Extremely Narrow Silicon Nanowire MOSFETs with Width down to 2nm. IEICE Technical Report; IEICE Tech. Rep.. 115(190). 1–2. 2 indexed citations
18.
Suzuki, Ryosuke, Kenji Saito, Takanobu Kato, et al.. (2012). Trans-complemented hepatitis C virus particles as a versatile tool for study of virus assembly and infection. Virology. 432(1). 29–38. 26 indexed citations
19.
Ando, Tomomi, Hiromi Imamura, Ryosuke Suzuki, et al.. (2012). Visualization and Measurement of ATP Levels in Living Cells Replicating Hepatitis C Virus Genome RNA. PLoS Pathogens. 8(3). e1002561–e1002561. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026